Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux
暂无分享,去创建一个
C. Glass | H. Brewer | C. Nicol | F. Gonzalez | M. Ricote | T. Akiyama | K. Matsusue | Ying‐Hue Lee | G. Lambert | S. Pimprale | S. Sakai | Ying-Hue Lee | Satish S. Pimprale
[1] E. Tsilibary,et al. The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. , 1988, The Journal of biological chemistry.
[2] D. Rader,et al. ABC1: connecting yellow tonsils, neuropathy, and very low HDL. , 1999, The Journal of clinical investigation.
[3] R. Evans,et al. A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .
[4] S. Fazio,et al. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation , 1995, Science.
[5] M. Brown,et al. Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. , 1982, The Journal of biological chemistry.
[6] D. Leroith,et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. , 2009, The Journal of biological chemistry.
[7] J. Auwerx,et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Huttunen,et al. Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.
[9] D. Rader,et al. Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E* , 2001, The Journal of Biological Chemistry.
[10] K. Petersen,et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. , 2002, The Journal of clinical investigation.
[11] B. Spiegelman,et al. PPARγ and the control of adipogenesis , 1997 .
[12] Margaret S. Wu,et al. Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.
[13] J. Taylor,et al. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. , 1995, The Journal of clinical investigation.
[14] K. Matsumoto,et al. Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses. , 1997, Biochemical and biophysical research communications.
[15] M. Karin,et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.
[16] B. Spiegelman,et al. 15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.
[17] M. Porta,et al. The role of endothelium in the pathogenesis of diabetic microangiopathy , 2004, Acta Diabetologica.
[18] P. Colville-Nash,et al. Cyclopentenone prostaglandins—new allies in the war on inflammation , 2000, Nature Medicine.
[19] L. Curtiss,et al. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. , 1995, The Journal of clinical investigation.
[20] R. Garlick,et al. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. , 1983, The Journal of biological chemistry.
[21] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[22] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[23] T. Chatila,et al. Cyclosporin A‐sensitive induction of the Epstein‐Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member , 1997, The EMBO journal.
[24] P. Edwards,et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.
[25] A. Schmidt,et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.
[26] S. Gordon,et al. Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function , 1994, The Journal of experimental medicine.
[27] V. Pasceri,et al. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. , 2000, Circulation.
[28] T. Hla,et al. The Nuclear Receptor PPARγ and Immunoregulation: PPARγ Mediates Inhibition of Helper T Cell Responses1 , 2000, The Journal of Immunology.
[29] Y. Matsuzawa,et al. Peroxisome Proliferator‐activated Receptor γ Induces Growth Arrest and Differentiation Markers of Human Colon Cancer Cells , 1999, Japanese journal of cancer research : Gann.
[30] S. Takasawa,et al. Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes. , 2002, Journal of molecular and cellular cardiology.
[31] J. Björkegren,et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. , 1999, The Journal of clinical investigation.
[32] F. Hobbs,et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.
[33] M. Smith,et al. Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link , 1996, Diabetologia.
[34] C. Franceschi,et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease , 2004, Journal of Medical Genetics.
[35] A. von Eckardstein,et al. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. , 1998, The Journal of clinical investigation.
[36] J. Lehmann,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[37] C. Glass,et al. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .
[38] A. Vaughan,et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. , 1999, The Journal of clinical investigation.
[39] K. Umesono,et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.
[40] D. Mangelsdorf,et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Bucala,et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Edwards,et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[43] B. Spiegelman,et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] B. Spiegelman. Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity. , 1997, European journal of medical research.
[45] R. Østerby,et al. Diabetic Glomerulopathy: Structural Characteristics of the Early and Advanced Stages , 1983, Diabetes.
[46] R. Mooney,et al. Interleukin-6 induces cellular insulin resistance in hepatocytes. , 2002, Diabetes.
[47] B. Spiegelman,et al. PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .
[48] M. Ghazzi,et al. Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. , 1997 .
[49] R. Zechner,et al. Role of Macrophage-Derived Lipoprotein Lipase in Lipoprotein Metabolism and Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[50] T. Chang,et al. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. , 2000, Cancer research.
[51] M. Brown,et al. Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages. , 1983, Science.
[52] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.
[53] Todd G. KirchgessnerS,et al. The Sequence of cDNA Encoding Lipoprotein Lipase , 1987 .
[54] M F Sanner,et al. Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.
[55] N. Cairns,et al. Evidence against increased glycoxidation in patients with Alzheimer's disease , 1997, Neuroscience Letters.
[56] E. Fleck,et al. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. , 2000, European journal of pharmacology.
[57] K. Chien,et al. PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development , 1999 .
[58] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[59] K. Cunningham,et al. A conserved family of calcineurin regulators. , 2000, Genes & development.
[60] T. Kislinger,et al. Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.
[61] K. O. Elliston,et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.
[62] H P Koeffler,et al. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[63] K. Maeda,et al. Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. , 1999, Biochemical and biophysical research communications.
[64] S. Skarlatos,et al. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. , 1994, The Journal of biological chemistry.
[65] N. Patel,et al. Agonists of Peroxisome-Proliferator Activated Receptor-Gamma Reduce Renal Ischemia/Reperfusion Injury , 2003, American Journal of Nephrology.
[66] M. Linton,et al. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[67] Alan W. Stitt,et al. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. , 1997, The American journal of pathology.
[68] F. Alt,et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[69] G. Münch,et al. Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and 'advanced glycation endproducts' in a murine microglia cell line. , 2002, The European journal of neuroscience.
[70] J. Sutcliffe,et al. Transcriptional activation of the mouse Mx gene by type I interferon , 1986, Molecular and cellular biology.
[71] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[72] P. Libby,et al. Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro , 1998 .
[73] A. Ott. Risk of dementia: The Rotterdam Study , 1997 .
[74] C. Glass,et al. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway , 2000 .
[75] H. Kruth,et al. Apolipoprotein E Produced by Human Monocyte-derived Macrophages Mediates Cholesterol Efflux That Occurs in the Absence of Added Cholesterol Acceptors* , 1996, The Journal of Biological Chemistry.
[76] A. Tall,et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. , 2000, The Journal of biological chemistry.
[77] Anne Dawnay,et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. , 2003, The Biochemical journal.
[78] A. Gotto,et al. Induction of CD 36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-g , 2000 .
[79] L. Dory. Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: effect of cholesterol efflux. , 1989, Journal of lipid research.
[80] A. Cerami,et al. Specific Macrophage Receptor Activity for Advanced Glycosylation End Products Inversely Correlates With Insulin Levels In Vivo , 1988, Diabetes.
[81] E. Friedman,et al. Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.
[82] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[83] R. Walczak,et al. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. , 2002, Journal of lipid research.
[84] D. Mangelsdorf,et al. Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages , 2000, The Journal of Biological Chemistry.
[85] Jung-Hoon Kang. Modification and inactivation of human Cu,Zn-superoxide dismutase by methylglyoxal. , 2003, Molecules and cells.
[86] Paul J Thornalley,et al. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. , 1994, The Journal of biological chemistry.
[87] P. Traldi,et al. Glyoxal and Methylglyoxal Levels in Diabetic Patients: Quantitative Determination by a New GC/MS Method , 2003, Clinical chemistry and laboratory medicine.
[88] C. Franceschi,et al. The invertebrate phagocytic immunocyte: clues to a common evolution of immune and neuroendocrine systems. , 1997, Immunology today.
[89] P. Mertz,et al. Calcineurin: form and function. , 2000, Physiological reviews.
[90] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.
[91] W. Trojaborg,et al. Antagonism of RAGE suppresses peripheral nerve regeneration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[92] T. Kodama,et al. Inhibition of oxidation of low density lipoprotein by troglitazone. , 1996, Atherosclerosis.
[93] B. Knebel,et al. Insulin-activated Erk-mitogen-activated Protein Kinases Phosphorylate Sterol Regulatory Element-binding Protein-2 at Serine Residues 432 and 455 in Vivo* , 2004, Journal of Biological Chemistry.
[94] S. Manna,et al. Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-kappaB activation and reactive oxygen intermediates. , 1999, Journal of immunology.
[95] Jerrold M. Ward,et al. Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis , 2001, Molecular and Cellular Biology.
[96] B. O’Malley,et al. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. , 1993, Biochemical and biophysical research communications.
[97] T. Mazzone,et al. Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3. , 1994, Journal of lipid research.
[98] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[99] H P Koeffler,et al. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. , 1998, Cancer research.
[100] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.
[101] M. Brownlee. The pathological implications of protein glycation. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.
[102] P. Chambon,et al. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[103] K. Pyörälä. Diabetes and Coronary Artery Disease: What a Coincidence? , 1990, Journal of cardiovascular pharmacology.
[104] J. Witztum,et al. The oxidation hypothesis of atherosclerosis , 1994, The Lancet.
[105] D. Harrison,et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. , 1996, The Journal of clinical investigation.
[106] S. Manna,et al. Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation , 2003, Oncogene.
[107] P. Riederer,et al. High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expression , 1999 .
[108] S. Wright,et al. 15-Deoxy-Δ12,1412,14-prostaglandin J2 Inhibits the β2 Integrin-Dependent Oxidative Burst: Involvement of a Mechanism Distinct from Peroxisome Proliferator-Activated Receptor γ Ligation , 1999, The Journal of Immunology.
[109] H. Joller-jemelka,et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.
[110] Michael Karin,et al. Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.
[111] A. Schmidt,et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.
[112] L. Yesner,et al. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. , 1996, Blood.
[113] R. Hammer,et al. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. , 1998, The Journal of clinical investigation.
[114] M. Kitahara,et al. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARγ) on human monocyte function: PPARγ ligands do not inhibit tumor necrosis factor-α release in human monocytic cell line THP-1 , 2004, Cell Biology and Toxicology.
[115] M Aguet,et al. Inducible gene targeting in mice , 1995, Science.
[116] V. J. Stevens,et al. Diabetic cataract formation: potential role of glycosylation of lens crystallins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[117] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[118] J. Katz,et al. Cutting Edge: Impaired Toll-Like Receptor Expression and Function in Aging , 2002, The Journal of Immunology.
[119] G. Landreth,et al. Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer’s disease , 2001, Neurobiology of Aging.
[120] Samuel Singer,et al. Differentiation and reversal of malignant changes in colon cancer through PPARγ , 1998, Nature Medicine.
[121] B. Staels,et al. Regulation of Lipid and Lipoprotein Metabolism by PPAR Activators , 2000, Clinical chemistry and laboratory medicine.
[122] Mayur B. Patel,et al. Macrophage Lipoprotein Lipase Promotes Foam Cell Formation and Atherosclerosis in Low Density Lipoprotein Receptor-deficient Mice* , 2000, The Journal of Biological Chemistry.
[123] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[124] Sawsan Youssef,et al. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine , 2002, Nature Medicine.
[125] T. Mazzone,et al. Transcriptional and post-transcriptional control of apolipoprotein E gene expression in differentiating human monocytes. , 1992, The Journal of biological chemistry.
[126] J Auwerx,et al. PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. , 1996, The EMBO journal.
[127] C. Franceschi,et al. Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .
[128] H. Brewer,et al. Regulation and intracellular trafficking of the ABCA1 transporter. , 2001, Journal of lipid research.
[129] E. Kohner,et al. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[130] J. Pennington,et al. Brefeldin A rapidly disrupts plasma membrane polarity by blocking polar sorting in common endosomes of MDCK cells. , 2001, Journal of cell science.
[131] Yukiko Kurihara,et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.
[132] Peter J. Brown,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .
[133] D. Altshuler,et al. The role of PPAR-γ in macrophage differentiation and cholesterol uptake , 2001, Nature Medicine.
[134] S. Wright,et al. 15-Deoxy-Delta12,1412,14-prostaglandin J2 inhibits the beta2 integrin-dependent oxidative burst: involvement of a mechanism distinct from peroxisome proliferator-activated receptor gamma ligation. , 1999, Journal of immunology.
[135] D. Kass,et al. Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker , 2001, Circulation.
[136] R. Lawn,et al. ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.
[137] T. Okura,et al. Troglitazone induces apoptosis via the p53 and Gadd45 pathway in vascular smooth muscle cells. , 2000, European journal of pharmacology.
[138] D. J. Kudzma. Effects of thiazolidinediones for early treatment of type 2 diabetes mellitus. , 2002, The American journal of managed care.
[139] D. Faxon,et al. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. , 1996, The Journal of clinical investigation.
[140] A. Schmidt,et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. , 1996, Nature.
[141] T. Koschinsky,et al. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[142] M. Yamauchi,et al. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus. , 1998, The Journal of clinical endocrinology and metabolism.
[143] Raj Kalaria,et al. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease. , 2004, Free radical biology & medicine.
[144] Rajnish A. Gupta,et al. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells , 1998 .
[145] A. von Eckardstein,et al. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages , 2000, Journal of Molecular Medicine.
[146] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[147] R. Bain,et al. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). , 1999, Controlled clinical trials.
[148] G. Paolisso,et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. , 2000, The Journal of clinical endocrinology and metabolism.
[149] V. D’Agati,et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. , 2003, The American journal of pathology.
[150] Hao Ren,et al. Regulation of the Calmodulin-stimulated Protein Phosphatase, Calcineurin* , 1998, The Journal of Biological Chemistry.
[151] W. Stallings,et al. Structure and topological symmetry of the glyphosate target 5-enolpyruvylshikimate-3-phosphate synthase: a distinctive protein fold. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[152] Jeffrey W. Smith,et al. Stochastic Gene Expression in a Single Cell , 2022 .
[153] M. Jaye,et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.
[154] D. Longo,et al. Bcl-2–mediated Drug Resistance: Inhibition of Apoptosis by Blocking Nuclear Factor of Activated T Lymphocytes (NFAT)-induced Fas Ligand Transcription , 1999 .
[155] Paul J Thornalley,et al. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.
[156] H. Shimano,et al. Absence of Sterol Regulatory Element-binding Protein-1 (SREBP-1) Ameliorates Fatty Livers but Not Obesity or Insulin Resistance inLep ob /Lep ob Mice* , 2002, The Journal of Biological Chemistry.
[157] R. Lawn,et al. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. , 2000, Biochemical and biophysical research communications.
[158] H. Huttunen,et al. Regulation of cell migration by amphoterin. , 2000, Journal of cell science.
[159] G. Sudlow,et al. Further characterization of specific drug binding sites on human serum albumin. , 1976, Molecular pharmacology.
[160] M. Linton,et al. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. , 1999, The Journal of clinical investigation.
[161] Satoshi Tanaka,et al. PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .
[162] J. Lehmann,et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). , 1995, The Journal of biological chemistry.
[163] K. Svenson,et al. The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family. , 1987, The Journal of biological chemistry.
[164] T. Langmann,et al. The Zinc Finger Protein 202 (ZNF202) Is a Transcriptional Repressor of ATP Binding Cassette Transporter A1 (ABCA1) and ABCG1 Gene Expression and a Modulator of Cellular Lipid Efflux* , 2001, The Journal of Biological Chemistry.
[165] S. Manna,et al. beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis. , 2004, The Journal of biological chemistry.
[166] R. Evans,et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.
[167] C. Franceschi,et al. Increased cytokine production in mononuclear cells of healthy elderly people , 1993, European journal of immunology.
[168] J. Baynes,et al. Role of the Maillard Reaction in Aging of Tissue Proteins , 1998, The Journal of Biological Chemistry.
[169] A. Vaughan,et al. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins. , 2000, Current opinion in lipidology.
[170] B. Spiegelman,et al. Terminal differentiation of human breast cancer through PPAR gamma. , 1998, Molecular cell.
[171] A. Barden,et al. Advanced Glycation End Products: A Review , 2013 .
[172] K. Otero,et al. Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products. , 2000, Circulation research.
[173] A. Gotto,et al. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. , 2000, Journal of lipid research.
[174] D. Mangelsdorf,et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. , 2000, Science.
[175] M. Huijberts,et al. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[176] J. Stelling,et al. Robustness of Cellular Functions , 2004, Cell.
[177] W. Hsueh,et al. Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells , 2000 .
[178] S. Kihara,et al. Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats. , 1998, Atherosclerosis.
[179] F. Shibasaki,et al. Intramolecular Masking of Nuclear Import Signal on NF-AT4 by Casein Kinase I and MEKK1 , 1998, Cell.
[180] G. Natoli,et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.
[181] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[182] S. Aizawa,et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. , 1999, Molecular cell.
[183] R. Silverstein,et al. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[184] A Hofman,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[185] G. Schmitz,et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[186] Barry M. Forman,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .
[187] A. W. Schüttelkopf,et al. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.
[188] D. Müller-Wieland,et al. MAP Kinases Erk1/2 Phosphorylate Sterol Regulatory Element-binding Protein (SREBP)-1a at Serine 117 in Vitro * , 2000, The Journal of Biological Chemistry.
[189] J. Blenis,et al. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases , 1997, Oncogene.